Colon cancer with a synchronous ovarian metastasis is occasionally dia
gnosed at the time of laparotomy for a pelvic mass. The purpose of thi
s retrospective study is to evaluate the clinical presentation as well
as the impact of the type of metastatic spread and surgical intervent
ion on overall survival. We reviewed charts of 23 patients treated bet
ween 1980 and 1995. Pain was the initial symptom in 14 patients (61%),
with only four patients (17%) complaining of rectal bleeding, but wit
h five patients (22%) complaining of uterine bleeding. At the time of
laparotomy, the ovarian capsule was intact in 12 patients. Metastatic
disease to the peritoneum was seen in seven patients and to the liver
in six patients. On pathological evaluation, the median ovarian tumor
size was 10 cm, significantly larger than the median colon tumor size
of 4.5 cm. Surgical treatment consisted of colon resection in all but
one patient, bilateral or unilateral salpingo-oophorectomy in 22 patie
nts, and hysterectomy in nine patients. Only one patient survived 5 ye
ars. Sixteen patients died of colon cancer. The median survival time w
as 17.8 months, ranging from 1 to 86 months. Tumor size was of no prog
nostic importance. Median survival time of patients with peritoneal di
sease (10.8 months) was significantly shorter compared to patients wit
hout peritoneal disease (25.2 months). In the presence of liver metast
asis, the median survival time was, likewise, significantly reduced fr
om 20.1 months to 8.1 months. In conclusion, macroscopic metastatic di
sease to the ovary is a poor prognostic factor in colon cancer. In sel
ected patients who can be rendered disease-free by surgery, prolonged
survival is possible and an aggressive approach is recommended. Surviv
al of patients with peritoneal disease or liver metastasis is short an
d a mainly palliative approach is recommended. (C) 1997 Academic Press
.